Document is current
Any future updates will be listed below
-
Authors
Shishido, Ana Claudia Laureano Navarro
Tostes, Livia Leão Leite
de Souza Nobre, Bryanne Brissian
Gonçalves, Jacqueline Rosa
de Sousa Mendes, Lucas Alexandre
Carbone, Ana Claudia
Sánchez-Ayala, Alfonso
Câmara-Souza, Mariana Barbosa
De la Torre Canales, Giancarlo https://orcid.org/0000-0002-0921-342X
-
Funding
Funding for this research was provided by:
Agência Regional para o Desenvolvimento da Investigação, Tecnologia e Inovação (UID/4585/2025)
Karolinska Institute
- License Information
-
More Information
Article History
Received: 19 December 2025
Accepted: 22 May 2026
First Online: 8 July 2026
Declarations
:
: This study was supported with an unconditional grant by FCT—Fundação para a Ciência e Tecnologia, I.P (UID/4585/2025). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder had no impact on the outcome of the clinical reports collection. The author A.C.C works as a speaker for Galderma, Brazil. Livia Leao Leite Tostes works as a speaker for AbbVie (Allergan). Galderma and AbbVie Brazil had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The company had no impact on the outcome of the study. All other authors declare no conflicts of interest.
: The study protocol received ethical approval from the Research Ethics Committee of Uninga University (CAAE: 81365624.1.0000.5220) and adhered to the principles outlined in the Declaration of Helsinki. Written and signed informed consent was obtained from all participants prior to enrollment in the study and for the publication of any potentially identifiable images included in this article.
